

Оксиморфон
- английское имяOXYMORPHONE
- CAS №76-41-5
- CBNumberCB8317944
- ФормулаC17H19NO4
- мольный вес301.34
- EINECS200-959-7
- номер MDLMFCD00079194
- файл Mol76-41-5.mol
химическое свойство
Температура плавления | 248-249°C (dec) |
Температура кипения | 518.6±50.0 °C(Predicted) |
плотность | 1.50±0.1 g/cm3(Predicted) |
Fp | 9℃ |
температура хранения | Controlled Substance, -20°C Freezer |
растворимость | Soluble in DMSO |
форма | Powder |
пка | pKa 8.50 (Uncertain);9.33 (Uncertain) |
Рейтинг продуктов питания EWG | 1 |
Словарь онкологических терминов NCI | Numorphan |
FDA UNII | 9VXA968E0C |
Словарь наркотиков NCI | Numorphan |
Код УВД | N02AA11 |
Система регистрации веществ EPA | Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5.alpha.)- (76-41-5) |
Коды опасности | F,T,T+ | |||||||||
Заявления о рисках | 11-23/24/25-39/23/24/25-26/27/28 | |||||||||
Заявления о безопасности | 16-36/37-45-36/37/39-22 | |||||||||
РИДАДР | UN1230 - class 3 - PG 2 - Methanol, solution | |||||||||
WGK Германия | 1 | |||||||||
кода HS | 2939110000 | |||||||||
Банк данных об опасных веществах | 76-41-5(Hazardous Substances Data) | |||||||||
NFPA 704: |
|
рисовальное письмо(GHS)
-
рисовальное письмо(GHS)
-
сигнальный язык
предупреждение
-
вредная бумага
H302:Вредно при проглатывании.
H336:Может вызывать сонливость или головокружение.
-
оператор предупредительных мер
P301+P312+P330:ПРИ ПРОГЛАТЫВАНИИ: Обратиться за медицинской помощью при плохом самочувствии. Прополоскать рот.
Оксиморфон химические свойства, назначение, производство
Химические свойства
Crystalline SolidИспользование
Controlled substance (opiate). Analgesic (narcotic)Биологические функции
Oxymorphone is 10 times as potent as morphine, with actions similar to those of hydromorphone. Oxymorphone, however, has little antitussive activity, and as such is a useful analgesic in patients with pulmonary disease who need to retain the ability to cough.Общее описание
Oxymorphone is the 14 beta-hydroxyl version of hydromorphone,analogous to the hydrocodone, oxycodone pair discussedabove. Although the addition of the 14 beta-hydroxylgroup to hydrocodone (30 mg) yielded oxycodone (20 mg),a more potent drug, the opposite is true for the conversion ofhydromorphone (7.5 mg) to oxymorphone (10 mg). The reasonfor this is that the oral bioavailability of oxymorphone(10%) is lower than that of hydromorphone (35%) becauseof decreased absorption and increased first-pass metabolism.Presumably, the addition of the OH group does increaseits binding affinity at the receptor as the injectableform of oxymorphone (1 mg) is more potent than injectablehydromorphone (1.5 mg).Oxymorphone is available as a suppository (5 mg), an injection(1 mg/mL), an immediate-release tablet (5 mg, 10mg), and in 2003 the FDA approved a sustained release formulation(Opana ER 5 mg, 10 mg, 20 mg, and 40 mg). The12-hour coverage of the extended release tablet provides anotheroption for those patients suffering from chronic pain.The side effect profile of the extended release formulationsof morphine, oxycodone, and oxymorphone are similar, andthere appears to be no clear advantage of one over the other.
Оксиморфон запасные части и сырье
сырьё
запасной предмет